Nabla

A health tech company that developed an ambient AI assistant for clinicians

Takeda inks $1.7B AI discovery deal with Iambic Therapeutics

The project aims to advance certain Takeda small molecules, with the work starting in the oncology, gastrointestinal and inflammation treatment areas.

Will Maddox Feb 9, 2026 8:00am

Takeda leader says AI gave early-stage asset a 'phoenix' rebirth

Jan 13, 2026 6:16am

Wood shavings and chisels on a workbench

Takeda turns to AI drug designer after whittling down R&D focus

Oct 14, 2025 5:00am